Analyst Conference Summaries

Biotechnology Investor Aids

Syros Pharmaceuticals
SYRS

conference date: May 14, 2024 @ 5:30 AM Pacific Time

Syros Pharmaceuticals A Buy on Price, Pipeline Potential [January 15, 2023 at Seeking Alpha]

Syros Pharmaceuticals Is A Buy As New Trials Start [November 19, 2021 at Seeking Alpha]

Syros Pharmaceuticals After the Orsenix Deal [December 29, 2020 at Seeking Alpha]

2024
Syros
Pharmaceuticals
Q4 2023
Syros
Pharmaceuticals
Q1 2024
   
March 27, 2024 May 14, 2024    
2023
Syros
Pharmaceuticals
Q4 2022
Syros
Pharmaceuticals
Q1 2023
Syros
Pharmaceuticals
Q2 2023
Syros
Pharmaceuticals
Q3 2023
March 2, 2023 May 10, 2023 Aug. 8, 2023 Nov. 14, 2023
2022
Syros
Pharmaceuticals
Q4 2021
Syros
Pharmaceuticals
Q1 2022
Syros
Pharmaceuticals
Q2 2022
Syros
Pharmaceuticals
Q3 2022
March 15, 2022 May 16, 2022 Aug. 9, 2022 Nov. 14, 2022
2021
Syros
Pharmaceuticals
Q4 2020
Syros
Pharmaceuticals
Q1 2021
Syros
Pharmaceuticals
Q2 2021
Syros
Pharmaceuticals
Q3 2021
March 4, 2021 May 6, 2021 Aug. 5, 2021 Nov. 5, 2021
2020
Syros
Pharmaceuticals
Q4 2019
Syros
Pharmaceuticals
Q1 2020
Syros
Pharmaceuticals
Q2 2020
Syros
Pharmaceuticals
Q3 2020
March 5, 2020 May 7, 2020 Aug. 6, 2020 Nov. 5, 2020

Syros Pharmaceuticals Update: Still a Buy [January 23, 2020 at Seeking Alpha]

Syros Pharmaceuticals Platform Undervalued [April 10, 2019 at Seeking Alpha]

Syros Pharmaceuticals (SYRS) is a clinical-stage biotechnology company with a platform based on gene regulation.

Syros Pharmaceutical web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BLRX
 BLUE
 BMY
 CLDX
 CDTX
 FATE
 GILD
 GLYC
 INCY
 INO
 IONS
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SAGE
 SANA
 TSVT
 VRTX
 VSTM
 WBA
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2024 William P. Meyers